henson-blog-default-image-1

Studies Show Avastin® Has Weak Results Against Ovarian Cancer

December 29, 2011

New studies are showing that a drug once used to treat numerous types of cancer may not work. According to WRAL News, recent data presented to the Food and Drug Administration (FDA) not only led to the organization pulling approval for the use of the drug Avastin® in the treatment of breast cancer, but now also in the treatment of ovarian cancer.

The drug was approved last week for use in advanced ovarian cancer patients despite the findings, but the drug’s manufacturer, Genentech, has stayed mum on whether the company will seek approval for the same in the United States.

Two studies in today’s newest issue of the New England Journal of Medicine found that the drug only slowed the cancers progression for several months and did not improve mortality rates. On top of this, patients have suffered from numerous drug side effects, including:

  • Blood Clots
  • Slow Wound Healing
  • Severe Bleeding
  • Perforations Of The Gastrointestinal Tract

If you or someone you love has suffered ill effects from drugs like Avastin®, contact the experienced team of North Carolina drug injury lawyers with HensonFuerst. They are here to help their clients in every step of the process of filing a claim to get the compensation they deserve.

Talk with us for Free.

The Henson Fuerst attorneys are always ready to talk to you about your case at absolutely no cost to you. We’ll answer questions that you may have and help you get back on your feet.

Home Page Evaluation Form

Free Case Evaluation

Name(Required)
This field is for validation purposes and should be left unchanged.

Our Locations

henson-location-row-building_1

RALEIGH OFFICE

3110 Edwards Mill Rd
Suite 210
Raleigh, NC 27612
(919) 781-1107
Fax: (919) 781-8048
View in Google Maps

ROCKY MOUNT OFFICE

2317 Sunset Ave.
Rocky Mount, NC 27804
(252) 443-2111
Fax: (252) 443-9429
View in Google Maps

BOONE OFFICE

(828) 295-7469

*By Appointment Only

Scroll to Top
Skip to content